Buprenorphine vs Rituximab
Buprenorphine vs Rituximab: Overview
This comparison examines the pharmacological differences between Buprenorphine and Rituximab.
Mechanism of Action
Buprenorphine: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Buprenorphine — 24-42 hours; Rituximab — 22 days.
Chemical Properties
Molecular Formula: Buprenorphine — C29H41NO4.
Molecular Weight: Buprenorphine — 467.6430 g/mol.
Type: Buprenorphine — Small molecule; Rituximab — Antibody.